Sethuraman Subramanian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sethuraman Subramanian has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Michael H. Sieweke
Aix Marseille University, CNRS, INSERM, CIML, Marseille, France
5 shared publications Gregory Gimenez
Aix-Marseille University, CNRS, INSERM, CIML, Marseille, France
2 shared publicationsHassiba Belahbib
Aix-Marseille University, CNRS, INSERM, CIML, Marseille, France
2 shared publications- Jiffin Benjamin
TU Dresden, Center for Regenerative Therapies Dresden (CRTD), 01307 Dresden, Germany
2 shared publications Julien Maurizio
Inovarion, Paris, France
2 shared publications- Julien Subburayalu
TU Dresden, Center for Regenerative Therapies Dresden (CRTD), 01307 Dresden, Germany
2 shared publications
Latest Publications
- Open Access
Stemness overcomes IFNγ-induced antitumour exhaustion in human macrophages
Macrophages hold great promise for antitumour therapies 1–4 , particularly owing to their ability to infiltrate solid tumours 5 . Yet therapeutic success has been limited 6,7 , because macrophages exhibit rapid exhaustion of antitumorigenic activity in the tumour 5,8,9 . Here, we induced a stem-like self-renewal programme in human induced pluripotent stem cell (iPSC)-derived macrophages by deleting the self-renewal restricting transcription factors MAFB and MAF (MAF-DKO). Human MAF-DKO macrophages showed activated stem cell signatures, increased clonogenicity and proliferative potential. Increased self-renewal capacity was accompanied by enhanced mitochondrial fitness and invigorated energy metabolism. Importantly, these stemness features prevented exhaustion, cellular aging-associated parameters and loss of energy efficiency that are typically associated with proinflammatory macrophage activation. In addition, activated MAF-DKO macrophages showed a broad loss of IFNγ-triggered immunosuppressive pathways 10,11 , induced a super-activated state with robust cytotoxic activity and resisted exhaustion upon tumour cell exposure. Consequently, activated MAF-DKO macrophages showed intratumoral persistence with a stable antitumoral phenotype in vivo, conferred robust reduction of tumour burden and extended survival of tumourbearing mice. Together, this demonstrates that the induction of stemness in human macrophages can overcome critical roadblocks of antitumour therapy by conferring resistance to activation-triggered exhaustion of antitumour activity in the TME.
Open AccessStemness overcomes IFNγ-induced antitumour exhaustion in human macrophages
Macrophages hold great promise for antitumour therapies 1–4 , particularly owing to their ability to infiltrate solid tumours 5 . Yet therapeutic success has been limited 6,7 , because macrophages exhibit rapid exhaustion of antitumorigenic activity in the tumour 5,8,9 . Here, we induced a stem-like self-renewal programme in human induced pluripotent stem cell (iPSC)-derived macrophages by deleting the self-renewal restricting transcription factors MAFB and MAF (MAF-DKO). Human MAF-DKO macrophages showed activated stem cell signatures, increased clonogenicity and proliferative potential. Increased self-renewal capacity was accompanied by enhanced mitochondrial fitness and invigorated energy metabolism. Importantly, these stemness features prevented exhaustion, cellular aging-associated parameters and loss of energy efficiency that are typically associated with proinflammatory macrophage activation. In addition, activated MAF-DKO macrophages showed a broad loss of IFNγ-triggered immunosuppressive pathways 10,11 , induced a super-activated state with robust cytotoxic activity and resisted exhaustion upon tumour cell exposure. Consequently, activated MAF-DKO macrophages showed intratumoral persistence with a stable antitumoral phenotype in vivo, conferred robust reduction of tumour burden and extended survival of tumourbearing mice. Together, this demonstrates that the induction of stemness in human macrophages can overcome critical roadblocks of antitumour therapy by conferring resistance to activation-triggered exhaustion of antitumour activity in the TME.
- Open Access
Stroke-induced lipocalin-2-expressing red pulp macrophages reprogram peripheral immunity
Acute ischemic stroke (AIS) induces profound systemic immune alterations that contribute to infection susceptibility. Here, we identify lipocalin-2 (LCN-2) as a rapidly induced and conserved regulator of stroke-associated immunosuppression. Using 3-MACE-Seq, cytokine profiling, and immunofluorescence in C57BL/6J mice subjected to transient middle cerebral artery occlusion (tMCAO), we show that LCN-2 is strongly upregulated in splenic red pulp macrophages (RPMs) within 24 hours and again 7 days post-tMCAO. LCN-2-expressing RPMs form immunological synapses with CD3+ T cells, thereby impacting T cell trafficking. Recombinant LCN-2 directly reprogrammed T cells and monocytes toward hyporesponsive, tolerogenic phenotypes by suppressing inflammatory cytokines, impairing chemotaxis, enhancing phagocytosis, and uncoupling oxidative burst. Human spleens likewise displayed LCN-2-expressing CD68+ RPMs, and LCN-2 preconditioning of monocytes reproduced reduced HLA-DR, CD80, CD206, and ROS with increased uptake of E. coli bioparticles. These findings identify LCN-2 signaling as a central or-chestrator of stroke-induced peripheral immunoreprogramming and a potential therapeutic target to mitigate post-stroke immunodepression.
Open AccessStroke-induced lipocalin-2-expressing red pulp macrophages reprogram peripheral immunity
Acute ischemic stroke (AIS) induces profound systemic immune alterations that contribute to infection susceptibility. Here, we identify lipocalin-2 (LCN-2) as a rapidly induced and conserved regulator of stroke-associated immunosuppression. Using 3-MACE-Seq, cytokine profiling, and immunofluorescence in C57BL/6J mice subjected to transient middle cerebral artery occlusion (tMCAO), we show that LCN-2 is strongly upregulated in splenic red pulp macrophages (RPMs) within 24 hours and again 7 days post-tMCAO. LCN-2-expressing RPMs form immunological synapses with CD3+ T cells, thereby impacting T cell trafficking. Recombinant LCN-2 directly reprogrammed T cells and monocytes toward hyporesponsive, tolerogenic phenotypes by suppressing inflammatory cytokines, impairing chemotaxis, enhancing phagocytosis, and uncoupling oxidative burst. Human spleens likewise displayed LCN-2-expressing CD68+ RPMs, and LCN-2 preconditioning of monocytes reproduced reduced HLA-DR, CD80, CD206, and ROS with increased uptake of E. coli bioparticles. These findings identify LCN-2 signaling as a central or-chestrator of stroke-induced peripheral immunoreprogramming and a potential therapeutic target to mitigate post-stroke immunodepression.
- Top Cited Papers
- 24 February 2022
- Published by Springer Nature in Nature Immunology
- Vol. 23 (3) , 458-468
Long-term culture-expanded alveolar macrophages restore their full epigenetic identity after transfer in vivo
Alveolar macrophages (AMs), the resident macrophages of the lung, can be expanded ex vivo to generate large numbers of cells but show culture adaptations related to epigenetic and transcriptional changes. After transplantation into the lungs of mice, however, culture-expanded AMs lose these adaptations, fully restore in vivo identity and functionally reconstitute the AM pool.
- 24 February 2022
- Published by Springer Nature in Nature Immunology
- Vol. 23 (3) , 458-468
Top Cited PapersLong-term culture-expanded alveolar macrophages restore their full epigenetic identity after transfer in vivo
Alveolar macrophages (AMs), the resident macrophages of the lung, can be expanded ex vivo to generate large numbers of cells but show culture adaptations related to epigenetic and transcriptional changes. After transplantation into the lungs of mice, however, culture-expanded AMs lose these adaptations, fully restore in vivo identity and functionally reconstitute the AM pool.
- Open Access
- 22 December 2021
- Published by Springer Nature in Research Square
Long-term culture expanded alveolar macrophages restore full epigenetic identity in vivo
Alveolar macrophages (AM) are tissue resident macrophages of the lung that can be expanded in culture, but it is unknown to what extent culture affects their in vivo identity. Here we show that long-term ex vivo expanded mouse AM (exAM) maintain core AM gene expression but show culture adaptations related to adhesion, metabolism and proliferation. Strikingly, even after several months in culture exAM reacquired full transcriptional and epigenetic identity upon transplantation into the lung and could self-maintain in the natural niche long-term. Changes in open chromatin regions (OCR) observed in culture were fully reversible in transplanted exAM (texAM) and resulted in a gene expression profile indistinguishable from resident AM. Our results demonstrate that long-term proliferation of AM in culture does not compromise cellular identity in vivo. The demonstrated robustness of exAM identity provides new opportunities for mechanistic analysis and highlights the therapeutic potential of ex vivo expanded macrophages.
- 22 December 2021
- Published by Springer Nature in Research Square
Open AccessLong-term culture expanded alveolar macrophages restore full epigenetic identity in vivo
Alveolar macrophages (AM) are tissue resident macrophages of the lung that can be expanded in culture, but it is unknown to what extent culture affects their in vivo identity. Here we show that long-term ex vivo expanded mouse AM (exAM) maintain core AM gene expression but show culture adaptations related to adhesion, metabolism and proliferation. Strikingly, even after several months in culture exAM reacquired full transcriptional and epigenetic identity upon transplantation into the lung and could self-maintain in the natural niche long-term. Changes in open chromatin regions (OCR) observed in culture were fully reversible in transplanted exAM (texAM) and resulted in a gene expression profile indistinguishable from resident AM. Our results demonstrate that long-term proliferation of AM in culture does not compromise cellular identity in vivo. The demonstrated robustness of exAM identity provides new opportunities for mechanistic analysis and highlights the therapeutic potential of ex vivo expanded macrophages.
- Open Access
- 15 August 2019
- Published by Springer Nature in The EMBO Journal
- Vol. 38 (19) , e101233
Bhlhe40 and Bhlhe41 transcription factors regulate alveolar macrophage self‐renewal and identity
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- 15 August 2019
- Published by Springer Nature in The EMBO Journal
- Vol. 38 (19) , e101233
Open AccessBhlhe40 and Bhlhe41 transcription factors regulate alveolar macrophage self‐renewal and identity
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.